Xenetic Biosciences exchanges 129,084 warrants for 51,634 common shares; amends 2019 Purchase Agreement

Xenetic Biosciences, Inc.

Warrants to purchase 129,084 shares exchanged for 51,634 common shares (0.4 ratio); all warrants cancelled.
Section 4.12(b) of the 2019 Securities Purchase Agreement deleted as part of the amendment.
No cash or other securities involved; exchange treated as cashless exercise under Section 3(a)(9).
Company agreed to standstill from Nov 15-19, 2021, not to issue shares or file registration statements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.